arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Avita Medical, Inc.

RCEL Health Care Medical/Dental Instruments
$11.20
Today
as of Sep 4, 16:53 ET
Last 30 days +135.79% Jul 27 → Sep 04
$3.86 $5.83 $7.80 $9.77 $11.74 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$10.99
High
$11.39
Low
$10.80
Volume
$301,598
Avg Vol
$374,260
Mkt Cap
$248M
P/E (TTM)
—
Beta
—
52w High
$11.39
52w Low
$3.22
Div Yield
—
Shares Out
$31M

Recent Press Releases & News last 60 days · 18 items

Sep 2 · 20:10 PR GlobeNewswire
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
Aug 31 · 16:00 Zacks
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy
Aug 25 · 17:07 Simply Wall St.
AVITA Medical (RCEL) Stock Fair Value Rises After PermeaDerm Data And Analyst Target Increases
▸ Show all 18 press releases & news Free account →

Overview

52-week range
$3.22
$11
98% of range
Avg surprise (last 3)
-27.3%
Avg reaction (last 2)
+0.4%
50% positive
Latest IV / EM
97%
EM ±15.2% · $10 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.73$-0.61$-0.49$-0.37$-0.25 Actual $-0.37Actual $-0.41Actual $-0.34Actual $-0.73Actual $-0.60Actual $-0.62Actual $-0.53Est $-0.39Actual $-0.38Est $-0.26Actual $-0.46Actual $-0.35Est $-0.35Actual $-0.25 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-16M$-6M$3M$13M$23M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.25 — — — — financials
Thu May 14, 2026Mar/2026 $-0.35 $-0.35 0.0% +34.0% +2.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.46 — — — — financials
Thu Aug 7, 2025Jun/2025 $-0.38 $-0.26 -46.1% — — earnings
Thu May 8, 2025Mar/2025 $-0.53 $-0.39 -35.9% — -1.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.62 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.60 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.73 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.34 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.41 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.37 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$22M$19M—$17M$18M$19M—$20M
Cost of revenue$4M$4M—$3M$3M$3M—$3M
Gross profit$18M$16M—$14M$15M$16M—$16M
Operating income$-7M$-9M—$-9M$-11M$-12M—$-14M
Net income$-8M$-11M—$-13M$-10M$-14M—$-16M
EPS (diluted)$-0.25$-0.35—$-0.46$-0.38$-0.53—$-0.62

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$9M$8M$10M$15M$12M$10M$14M$41M
Inventory$5M$6M$7M$7M$8M$8M$7M$6M
Total current assets$28M$32M$35M$41M$36M$48M$57M$64M
Total assets$48M$52M$56M$64M$58M$70M$80M$81M
Long-term debt———$0$42M$41M$42M$43M
Total liabilities$76M$75M$73M$70M$71M$74M$75M$69M
Total equity$-28M$-23M$-17M$-7M$-13M$-5M$4M$12M

Implied volatility — last 90 days

57%171%285%398%512% Jun 07 — IV 147% · EM ±20.3%Jun 08 — IV 346% · EM ±45.7%Jun 09 — IV 194% · EM ±24.3%Jun 10 — IV 200% · EM ±23.7%Jun 11 — IV 217% · EM ±23.9%Jun 12 — IV 200% · EM ±20.5%Jun 15 — IV 361% · EM ±26.1%Jun 16 — IV 486% · EM ±28.7%Jun 17 — IV 486% · EM ±20.3%Jun 19 — IV 152% · EM ±33.7%Jun 22 — IV 172% · EM ±36.0%Jun 23 — IV 143% · EM ±29.3%Jun 24 — IV 145% · EM ±29.1%Jun 25 — IV 143% · EM ±28.1%Jun 26 — IV 148% · EM ±28.3%Jun 29 — IV 156% · EM ±27.6%Jun 30 — IV 176% · EM ±30.3%Jul 01 — IV 131% · EM ±21.9%Jul 02 — IV 67% · EM ±10.9%Jul 03 — IV 70% · EM ±10.9%Jul 06 — IV 153% · EM ±21.2%Jul 07 — IV 83% · EM ±11.0%Jul 08 — IV 60% · EM ±7.5%Jul 09 — IV 58% · EM ±6.8%Jul 10 — IV 513% · EM ±56.6%Jul 13 — IV 485% · EM ±40.5%Jul 15 — IV 160% · EM ±9.5%Jul 20 — IV 124% · EM ±29.2%Jul 21 — IV 114% · EM ±26.5%Jul 22 — IV 122% · EM ±27.8%Jul 23 — IV 135% · EM ±30.4%Jul 24 — IV 157% · EM ±34.7%Jul 27 — IV 121% · EM ±25.3%Jul 28 — IV 138% · EM ±28.2%Jul 29 — IV 155% · EM ±31.1%Jul 30 — IV 142% · EM ±27.8%Jul 31 — IV 142% · EM ±27.3%Aug 03 — IV 144% · EM ±25.4%Aug 04 — IV 157% · EM ±27.0%Aug 05 — IV 187% · EM ±31.3%Aug 06 — IV 94% · EM ±15.2%Aug 07 — IV 95% · EM ±14.9%Aug 10 — IV 83% · EM ±11.5%Aug 11 — IV 125% · EM ±16.5%Aug 12 — IV 91% · EM ±11.4%Aug 13 — IV 89% · EM ±10.5%Aug 14 — IV 61% · EM ±6.7%Aug 17 — IV 167% · EM ±13.9%Aug 18 — IV 244% · EM ±17.7%Aug 19 — IV 153% · EM ±9.0%Aug 24 — IV 77% · EM ±16.1%Aug 25 — IV 68% · EM ±14.0%Aug 26 — IV 97% · EM ±19.4%Aug 27 — IV 78% · EM ±15.3%Aug 28 — IV 86% · EM ±16.4%Aug 31 — IV 73% · EM ±12.9%Sep 01 — IV 76% · EM ±13.2%Sep 02 — IV 136% · EM ±22.8%Sep 03 — IV 89% · EM ±14.4%Sep 04 — IV 97% · EM ±15.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in